2nd Annual Clinical Trials in Rare Diseases Europe

Join Aixial Group to learn about best practices in orphan drug and rare disease trial design and execution!

Aixial Group will attend the 2nd Annual Clinical Trials in Rare Diseases Europe in Munich on 26–27 November 2025. Our business development representative, Denitza Christova, and rare disease expert, Laura Nichols, will participate in sessions focused on the unique challenges of orphan drug and rare disease trials. The event covers patient recruitment and retention, early engagement with regulatory authorities, and collaboration with patient advocacy groups.

Aixial Group brings experience in planning and executing rare disease studies, supporting sponsors to navigate complex regulations, engage patients effectively, and deliver meaningful outcomes for rare disease communities.